Status:
COMPLETED
Effects of Daily Walnut Intake Among the Subjects With Metabolic Syndrome
Lead Sponsor:
ICAN Nutrition Education and Research
Collaborating Sponsors:
California Walnut Commission
Conditions:
Metabolic Syndrome
Eligibility:
All Genders
30-55 years
Phase:
NA
Brief Summary
Investigators planed to conduct a randomized, controlled, crossover trial to examine the effects of daily walnuts intake among Korean subjects with metabolic syndrome. Primary objective of this study ...
Eligibility Criteria
Inclusion
- at least three out of five metabolic syndrome components
- waist circumference (WC) \>90 cm for men and \>80 cm for women
- hypertension (DBP ≥85 and \<110 mm Hg)
- hyperglycemia (≥100 mg/dL)
- elevated plasma TG concentrations (≥150 mg/dL)
- decreased plasma HDL-C concentrations (\<40 mg/dL for men and \<50 mg/dL for women)
Exclusion
- the presence of morbid obesity (BMI ≥40)
- the use of any medication for the control of blood pressure, glucose, or lipid metabolism
- a medical history of hypocaloric diet consumption within the past year
- gastrointestinal tract disorders
- post-menopausal women
- smokers
Key Trial Info
Start Date :
May 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 30 2017
Estimated Enrollment :
119 Patients enrolled
Trial Details
Trial ID
NCT03267901
Start Date
May 1 2015
End Date
July 30 2017
Last Update
August 30 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
ICAN Nutrition Education and Research
Seoul, South Korea, 07327